| Year |
Citation |
Score |
| 2022 |
Taurin S, Rosengren RJ. Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines. Medical Oncology (Northwood, London, England). 40: 45. PMID 36494506 DOI: 10.1007/s12032-022-01909-3 |
0.327 |
|
| 2017 |
Greish K, Jasim A, Parayath N, Abdelghany S, Alkhateeb A, Taurin S, Nehoff H. Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme. Journal of Drug Targeting. 1-17. PMID 29251531 DOI: 10.1080/1061186X.2017.1419357 |
0.372 |
|
| 2017 |
Martey O, Nimick M, Taurin S, Sundararajan V, Greish K, Rosengren RJ. Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer. International Journal of Nanomedicine. 12: 7225-7237. PMID 29042771 DOI: 10.2147/Ijn.S148908 |
0.318 |
|
| 2017 |
Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Janát-Amsbury MM. Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28953502 DOI: 10.1097/Igc.0000000000001129 |
0.321 |
|
| 2017 |
Taurin S, Yang C, Reyes M, Cho S, Jarboe EA, Werner TL, Coombs DM, Chen P, Janát-Amsbury MM. Abstract 3244: Treatment of endometrial cancer cells with a new small tyrosine kinase inhibitor targeting mutated fibroblast growth factor receptor-2 Cancer Research. 77: 3244-3244. DOI: 10.1158/1538-7445.Am2017-3244 |
0.377 |
|
| 2016 |
Archibald M, Pritchard T, Nehoff H, Rosengren RJ, Greish K, Taurin S. A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer. International Journal of Nanomedicine. 11: 179-200. PMID 26811677 DOI: 10.2147/Ijn.S97286 |
0.37 |
|
| 2015 |
Taurin S, Nimick M, Larsen L, Rosengren RJ. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. International Journal of Oncology. PMID 26648459 DOI: 10.3892/Ijo.2015.3252 |
0.393 |
|
| 2015 |
Nehoff H, Parayath NN, McConnell MJ, Taurin S, Greish K. A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme. Oncotarget. PMID 26517812 DOI: 10.18632/Oncotarget.5698 |
0.385 |
|
| 2015 |
Parayath NN, Nehoff H, Müller P, Taurin S, Greish K. Styrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells. International Journal of Nanomedicine. 10: 4653-67. PMID 26229468 DOI: 10.2147/Ijn.S87681 |
0.305 |
|
| 2015 |
Nehoff H, Parayath N, Taurin S, Greish K. ATPS-58COMBINATION TYROSINE KINASE INHIBITORS EFFECTIVELY OVERCOME THE APOPTOSIS RESISTANCE, INVASIVE POTENTIAL AND ANGIOGENIC CAPACITY OF GLIOBLASTOMA MULTIFORME CELLS Neuro-Oncology. 17: v31.1-v31. DOI: 10.1093/Neuonc/Nov204.58 |
0.418 |
|
| 2013 |
Taurin S, Allen KM, Scandlyn MJ, Rosengren RJ. Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression. International Journal of Oncology. 43: 785-92. PMID 23842642 DOI: 10.3892/Ijo.2013.2012 |
0.342 |
|
| 2012 |
Yadav B, Taurin S, Larsen L, Rosengren RJ. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models. International Journal of Oncology. 41: 1723-32. PMID 22971638 DOI: 10.3892/Ijo.2012.1625 |
0.404 |
|
| 2012 |
Yadav B, Taurin S, Larsen L, Rosengren RJ. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells. International Journal of Oncology. 41: 1119-27. PMID 22710975 DOI: 10.3892/Ijo.2012.1521 |
0.407 |
|
| 2012 |
Taurin S, Yadav BD, Nimick M, Rosengren RJ. Abstract 4669: A combination of raloxifene and gefitinib potentiates the cytotoxicity and induces apoptosis in estrogen receptor negative breast cancer cell lines Cancer Research. 72: 4669-4669. DOI: 10.1158/1538-7445.Am2012-4669 |
0.379 |
|
| 2011 |
Somers-Edgar TJ, Taurin S, Larsen L, Chandramouli A, Nelson MA, Rosengren RJ. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines. Investigational New Drugs. 29: 87-97. PMID 19816657 DOI: 10.1007/S10637-009-9339-0 |
0.406 |
|
| 2010 |
Yadav B, Taurin S, Rosengren RJ, Schumacher M, Diederich M, Somers-Edgar TJ, Larsen L. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorganic & Medicinal Chemistry. 18: 6701-7. PMID 20728364 DOI: 10.1016/J.Bmc.2010.07.063 |
0.395 |
|
| 2010 |
Yadav BD, Taurin S, Larsen L, Rosengren RJ. Abstract 3556: New curcumin analogues are cytotoxic towards estrogen receptor negative human breast cancer cell lines Cancer Research. 70: 3556-3556. DOI: 10.1158/1538-7445.Am10-3556 |
0.369 |
|
| 2009 |
Sun Q, Taurin S, Sethakorn N, Long X, Imamura M, Wang DZ, Zimmer WE, Dulin NO, Miano JM. Myocardin-dependent activation of the CArG box-rich smooth muscle gamma-actin gene: preferential utilization of a single CArG element through functional association with the NKX3.1 homeodomain protein. The Journal of Biological Chemistry. 284: 32582-90. PMID 19797053 DOI: 10.1074/Jbc.M109.033910 |
0.323 |
|
| 2009 |
Taurin S, Sandbo N, Yau DM, Sethakorn N, Kach J, Dulin NO. Phosphorylation of myocardin by extracellular signal-regulated kinase. The Journal of Biological Chemistry. 284: 33789-94. PMID 19776005 DOI: 10.1074/Jbc.M109.048983 |
0.334 |
|
| 2008 |
Akimova OA, Taurin S, Dulin NO, Orlov SN. Purinergic inhibition of Na⁺,K⁺,Cl⁻ cotransport in C11-MDCK cells: Role of stress-activated protein kinases. Purinergic Signalling. 4: 183-91. PMID 18368525 DOI: 10.1007/S11302-007-9057-Z |
0.578 |
|
| 2008 |
Taurin S, Sandbo N, Yau DM, Sethakorn N, Dulin NO. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. American Journal of Physiology. Cell Physiology. 294: C1169-74. PMID 18353896 DOI: 10.1152/Ajpcell.00096.2008 |
0.381 |
|
| 2007 |
Haloui M, Taurin S, Akimova OA, Guo DF, Tremblay J, Dulin NO, Hamet P, Orlov SN. [Na]i -induced c-Fos expression is not mediated by activation of the 5' -promoter containing known transcriptional elements. The Febs Journal. 274: 3557-67. PMID 17565602 DOI: 10.1111/J.1742-4658.2007.05885.X |
0.62 |
|
| 2007 |
Taurin S, Hogarth K, Sandbo N, Yau DM, Dulin NO. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3. The Journal of Biological Chemistry. 282: 19518-25. PMID 17513863 DOI: 10.1074/Jbc.M702655200 |
0.36 |
|
| 2007 |
Sandbo N, Taurin S, Yau DM, Kregel S, Mitchell R, Dulin NO. Downregulation of smooth muscle alpha-actin expression by bacterial lipopolysaccharide. Cardiovascular Research. 74: 262-9. PMID 17303098 DOI: 10.1016/J.Cardiores.2007.01.011 |
0.327 |
|
| 2006 |
Taurin S, Sandbo N, Qin Y, Dulin NO. 21 PHOSPHORYLATION OF b-CATENIN BY PROTEIN KINASE A IN VASCULAR SMOOTH MUSCLE CELLS. Journal of Investigative Medicine. 54: S347.1-S347. DOI: 10.2310/6650.2005.X0015.20 |
0.339 |
|
| 2005 |
Akimova AO, Bourcier N, Taurin S, Bundey RA, Grygorczyk K, Gekle M, Insel PA, Dulin NO, Orlov SN. Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P 2Y1 receptors, phospholipase A2 and protein kinase A. The Journal of Physiology. 568: 789-801. PMID 16109726 DOI: 10.1113/Jphysiol.2005.094375 |
0.569 |
|
| 2005 |
Sandbo N, Qin Y, Taurin S, Hogarth DK, Kreutz B, Dulin NO. Regulation of serum response factor-dependent gene expression by proteasome inhibitors. Molecular Pharmacology. 67: 789-97. PMID 15550677 DOI: 10.1124/Mol.104.006874 |
0.369 |
|
| 2004 |
Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, Dulin NO. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. American Journal of Physiology. Cell Physiology. 287: C449-56. PMID 15238360 DOI: 10.1152/Ajpcell.00547.2003 |
0.409 |
|
| 2004 |
Orlov SN, Thorin-Trescases N, Pchejetski D, Taurin S, Farhat N, Tremblay J, Thorin E, Hamet P. Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i. PflüGers Archiv : European Journal of Physiology. 448: 335-45. PMID 15069561 DOI: 10.1007/S00424-004-1262-9 |
0.63 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Thorin-Trescases N, Maximov GV, Pshezhetsky AV, Rubin AB, Hamet P. Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism. Apoptosis : An International Journal On Programmed Cell Death. 9: 55-66. PMID 14739599 DOI: 10.1023/B:Appt.0000012122.47197.03 |
0.64 |
|
| 2004 |
Taurin S, Pchejetski D, Thorin-Trescase N, Tremblay J, Harriet P, Orlov SN. INTRACELLULAR SODIUM PROTECTS VASCULAR ENDOTHELIAL CELLS FROM APOPTOSIS TRIGGERED BY [3H]-DECAY-INDUCED DNA DAMAGE Journal of Hypertension. 22: S50-S51. DOI: 10.1097/00004872-200406002-00169 |
0.576 |
|
| 2004 |
Orlov SN, Pchejetski D, Thorin-Trescase N, Taurin S, Tremblay J, Harriet P. ENDOTHELIAL CELL DEATH TRIGGERED BY OUABAIN Journal of Hypertension. 22: S9-S10. DOI: 10.1097/00004872-200406002-00024 |
0.573 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Tremblay J, Harriet P. APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS Journal of Hypertension. 22: S7. DOI: 10.1097/00004872-200406002-00014 |
0.575 |
|
| 2004 |
Orlov SN, Pchejetski D, Taurin S, Tremblay J, Hamet P. Apoptosis In Serum-Deprived Vascular Smooth Muscle Cells (Vsmc): Evidence For Cell Volume-Independent Mechanism Cardiovascular Pathology. 13: 166. DOI: 10.1016/J.Carpath.2004.03.501 |
0.589 |
|
| 2004 |
Hogarth DK, Sandbo N, Elinoff J, Taurin S, Dulin N. Dual Role Of Pka In The Phenotypic Modulation Of Vascular Smooth Muscle Cells By Extracellular Atp Cardiovascular Pathology. 13: 163. DOI: 10.1016/J.Carpath.2004.03.491 |
0.373 |
|
| 2004 |
Taurin S, Pchejetski D, Thorin-Trescases N, Tremblay J, Hamet P, Orlov SN. ELEVATION OF [NA+]I PROTECTS ENDOTHELIAL CELLS FROM APOPTOSIS TRIGGERED BY [3H]-DECAY-INDUCED DNA DAMAGE Cardiovascular Pathology. 13: 92. DOI: 10.1016/J.Carpath.2004.03.271 |
0.659 |
|
| 2004 |
Orlov SN, Thorin-Trescases N, Pchejetski D, Taurin S, Tremblay J, Hamet P. ENDOTHELIAL CELL DEATH TRIGGERED BY OUABAIN: EVIDENCE FOR NOVEL FUNCTION OF THE NA+,K+−ATPASE. Cardiovascular Pathology. 13: 54-55. DOI: 10.1016/J.Carpath.2004.03.160 |
0.622 |
|
| 2003 |
Taurin S, Hamet P, Orlov SN. [Na/K pump and intracellular monovalent cations: novel mechanism of excitation-transcription coupling involved in inhibition of apoptosis]. Molekuliarnaia Biologiia. 37: 371-81. PMID 12815944 DOI: 10.1023/A:1024266722564 |
0.635 |
|
| 2003 |
Orlov SN, Pchejetski DV, Sarkissian SD, Adarichev V, Taurin S, Pshezhetsky AV, Tremblay J, Maximov GV, deBlois D, Bennett MR, Hamet P. [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein. Apoptosis : An International Journal On Programmed Cell Death. 8: 199-208. PMID 12766480 DOI: 10.1023/A:1022931028235 |
0.631 |
|
| 2003 |
Pchejetski D, Taurin S, Der Sarkissian S, Lopina OD, Pshezhetsky AV, Tremblay J, deBlois D, Hamet P, Orlov SN. Inhibition of Na+,K+-ATPase by ouabain triggers epithelial cell death independently of inversion of the [Na+]i/[K+]i ratio. Biochemical and Biophysical Research Communications. 301: 735-44. PMID 12565842 DOI: 10.1016/S0006-291X(02)03002-4 |
0.622 |
|
| 2003 |
Orlov SN, Pchejetski DV, Sarkissian SD, Adarichev V, Taurin S, Pshezhetsky AV, Tremblay J, Maximov GV, DeBlois D, Bennett MR, Hamet P. [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein Apoptosis. 8: 199-208. DOI: 10.1023/A:1022931028235 |
0.594 |
|
| 2002 |
Taurin S, Seyrantepe V, Orlov SN, Tremblay TL, Thibault P, Bennett MR, Hamet P, Pshezhetsky AV. Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circulation Research. 91: 915-22. PMID 12433836 DOI: 10.1161/01.Res.0000043020.45534.3E |
0.649 |
|
| 2002 |
Taurin S, Dulin NO, Pchejetski D, Grygorczyk R, Tremblay J, Hamet P, Orlov SN. c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism. The Journal of Physiology. 543: 835-47. PMID 12231642 DOI: 10.1113/Jphysiol.2002.023259 |
0.592 |
|
| 2002 |
Taurin S, Ryazhsky GG, Maximova NV, Chuchalin AG, Hamet P, Pshezhetsky AV, Orlov SN. Suppression of programmed cell death by intracellular cAMP is not mediated by expression of genes encoding an inhibitor of apoptosis. Biochemistry. Biokhimii︠a︡. 67: 254-9. PMID 11952423 DOI: 10.1023/A:1014478417580 |
0.615 |
|
| 2002 |
Orlov SN, Taurin S, Hamet P. The alpha1-Na/K pump does not mediate the involvement of ouabain in the development of hypertension in rats. Blood Pressure. 11: 56-62. PMID 11926353 DOI: 10.1080/080370502753543972 |
0.592 |
|
| 2001 |
Orlov SN, Taurin S, Tremblay J, Hamet P. Inhibition of Na+,K+ pump affects nucleic acid synthesis and smooth muscle cell proliferation via elevation of the [Na+]i/[K+]i ratio: possible implication in vascular remodelling. Journal of Hypertension. 19: 1559-65. PMID 11564975 DOI: 10.1097/00004872-200109000-00007 |
0.639 |
|
| 2001 |
Thorin-Trescases N, Orlov SN, Taurin S, Dulin NO, Allen BG, deBlois D, Tremblay J, Pshezhetsky AV, Hamet P. Antiproliferative effect of brief exposure to cholera toxin in vascular smooth muscle cells: role of cAMP and protein kinase A. Canadian Journal of Physiology and Pharmacology. 79: 471-80. PMID 11430584 DOI: 10.1139/Y01-017 |
0.58 |
|
| 2000 |
Orlov SN, Taurin S, Thorin-Trescases N, Dulin NO, Tremblay J, Hamet P. Inversion of the intracellular Na(+)/K(+) ratio blocks apoptosis in vascular smooth muscle cells by induction of RNA synthesis. Hypertension. 35: 1062-8. PMID 10818065 DOI: 10.1161/01.Hyp.35.5.1062 |
0.62 |
|
| 2000 |
Orlov SN, Taurin S, Tremblay J, Hamet P. INTRACELLULAR Na+/K+ RATIO AND cAMP SIGNALLING Journal of Hypertension. 18: S76. DOI: 10.1097/00004872-200006001-00260 |
0.562 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Greish K, Mathur A, Al Zahrani R, Elkaissi S, Al Jishi M, Nazzal O, Taha S, Pittalà V, Taurin S. Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30367922 DOI: 10.1016/J.Jconrel.2018.10.030 |
0.294 |
|
| 2018 |
Greish K, Pittalà V, Taurin S, Taha S, Bahman F, Mathur A, Jasim A, Mohammed F, El-Deeb IM, Fredericks S, Rashid-Doubell F. Curcumin⁻Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer. Nanomaterials (Basel, Switzerland). 8. PMID 30388728 DOI: 10.3390/Nano8110884 |
0.293 |
|
| 2014 |
Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. International Journal of Nanomedicine. 9: 2539-55. PMID 24904213 DOI: 10.2147/Ijn.S47129 |
0.289 |
|
| 2014 |
Taurin S, Nehoff H, van Aswegen T, Rosengren RJ, Greish K. A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer. Biomed Research International. 2014: 323594. PMID 24689036 DOI: 10.1155/2014/323594 |
0.289 |
|
| 2009 |
Sandbo N, Kregel S, Taurin S, Bhorade S, Dulin NO. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta. American Journal of Respiratory Cell and Molecular Biology. 41: 332-8. PMID 19151320 DOI: 10.1165/Rcmb.2008-0288Oc |
0.284 |
|
| 2019 |
Greish K, Nehoff H, Bahman F, Pritchard T, Taurin S. Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor. Journal of Drug Targeting. 1-43. PMID 30615483 DOI: 10.1080/1061186X.2019.1566341 |
0.283 |
|
| 2018 |
Janát-Amsbury M, Taurin S, Yang C, Reyes M, Coombs D, Jarboe E, Werner T, Peterson C. Endometrial cancers are successfully targeted with a new pan-tyrosine kinase inhibitor in an orthotopic mouse model Gynecologic Oncology. 149: 61. DOI: 10.1016/J.Ygyno.2018.04.137 |
0.28 |
|
| 2006 |
Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. The Journal of Biological Chemistry. 281: 9971-6. PMID 16476742 DOI: 10.1074/Jbc.M508778200 |
0.277 |
|
| 2008 |
Yau DM, Sethakorn N, Taurin S, Kregel S, Sandbo N, Camoretti-Mercado B, Sperling AI, Dulin NO. Regulation of Smad-mediated gene transcription by RGS3. Molecular Pharmacology. 73: 1356-61. PMID 18287247 DOI: 10.1124/Mol.108.044990 |
0.276 |
|
| 2014 |
Mohamed S, Parayath NN, Taurin S, Greish K. Polymeric nano-micelles: versatile platform for targeted delivery in cancer. Therapeutic Delivery. 5: 1101-21. PMID 25418269 DOI: 10.4155/Tde.14.69 |
0.267 |
|
| 2021 |
Alkhalifa H, Mohammed F, Taurin S, Greish K, Taha S, Fredericks S. Inhibition of aquaporins as a potential adjunct to breast cancer cryotherapy. Oncology Letters. 21: 458. PMID 33907568 DOI: 10.3892/ol.2021.12719 |
0.267 |
|
| 2011 |
Nair SM, Rahman RM, Clarkson AN, Sutherland BA, Taurin S, Sammut IA, Appleton I. Melatonin treatment following stroke induction modulates L-arginine metabolism. Journal of Pineal Research. 51: 313-23. PMID 21605165 DOI: 10.1111/J.1600-079X.2011.00891.X |
0.264 |
|
| 2016 |
Pritchard T, Rosengren RJ, Greish K, Taurin S. Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer. Journal of Drug Targeting. 24: 441-9. PMID 26373825 DOI: 10.3109/1061186X.2015.1086360 |
0.263 |
|
| 2016 |
Parayath NN, Nehoff H, Norton SE, Highton AJ, Taurin S, Kemp RA, Greish K. Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model. International Journal of Nanomedicine. 11: 3979-91. PMID 27574427 DOI: 10.2147/Ijn.S110251 |
0.254 |
|
| 2013 |
Taurin S, Nehoff H, Diong J, Larsen L, Rosengren RJ, Greish K. Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer. Journal of Drug Targeting. 21: 675-83. PMID 23679865 DOI: 10.3109/1061186X.2013.796955 |
0.25 |
|
| 2018 |
Greish K, Taurin S, Morsy MA. The effect of adjuvant therapy with TNF-α on animal model of triple-negative breast cancer. Therapeutic Delivery. 9: 333-342. PMID 29681232 DOI: 10.4155/Tde-2017-0101 |
0.249 |
|
| 2017 |
Greish K, Taha S, Jasim A, Elghany SA, Sultan A, AlKhateeb A, Othman M, Jun F, Taurin S, Bakhiet M. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease. Clinical and Translational Medicine. 6: 28. PMID 28770521 DOI: 10.1186/S40169-017-0157-2 |
0.244 |
|
| 2012 |
Taurin S, Nehoff H, Greish K. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 265-75. PMID 22800576 DOI: 10.1016/J.Jconrel.2012.07.013 |
0.235 |
|
| 2017 |
Taurin S, Almomen AA, Pollak T, Kim SJ, Maxwell J, Peterson CM, Owen SC, Janát-Amsbury MM. Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery. Journal of Drug Targeting. 1-50. PMID 29096548 DOI: 10.1080/1061186X.2017.1400551 |
0.224 |
|
| 2018 |
Greish K, Mathur A, Bakhiet M, Taurin S. Nanomedicine: is it lost in translation? Therapeutic Delivery. PMID 29495928 DOI: 10.4155/Tde-2017-0118 |
0.223 |
|
| 2016 |
Parayath NN, Nehoff H, Taurin S, Greish K. Prospects of Nanocarriers for Oral Delivery of Bioactives Using Targeting Strategies. Current Pharmaceutical Biotechnology. 17: 683-99. PMID 27033507 DOI: 10.2174/1389201017666160401145608 |
0.22 |
|
| 2019 |
Greish K, Alqahtani AA, Alotaibi AF, Abdulla AM, Bukelly AT, Alsobyani FM, Alharbi GH, Alkiyumi IS, Aldawish MM, Alshahrani TF, Pittalà V, Taurin S, Kamal A. The Effect of Silver Nanoparticles on Learning, Memory and Social Interaction in BALB/C Mice. International Journal of Environmental Research and Public Health. 16. PMID 30625980 DOI: 10.3390/Ijerph16010148 |
0.211 |
|
| 2022 |
Palmer H, Nimick M, Mazumder A, Taurin S, Rana Z, Rosengren RJ. Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer. Biomedicines. 10. PMID 35453603 DOI: 10.3390/biomedicines10040853 |
0.19 |
|
| 2020 |
Taurin S, Alkhalifa H. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses. Neoplasia (New York, N.Y.). 22: 663-678. PMID 33142233 DOI: 10.1016/j.neo.2020.09.009 |
0.168 |
|
| 2021 |
Hassani N, Taurin S, Alshammary S. Meta-Analysis: The Clinical Application of Autologous Adult Stem Cells in the Treatment of Stroke. Stem Cells and Cloning : Advances and Applications. 14: 81-91. PMID 35002259 DOI: 10.2147/SCCAA.S344943 |
0.087 |
|
| 2023 |
Mathur A, Taurin S, Alshammary S. The Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes- A Literature Review. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 16: 769-777. PMID 36941907 DOI: 10.2147/DMSO.S392161 |
0.087 |
|
| 2022 |
Mathur A, Taurin S. What influence does mammographic density have on breast cancer occurrence? Expert Review of Anticancer Therapy. 22: 445-447. PMID 35416087 DOI: 10.1080/14737140.2022.2065985 |
0.075 |
|
| 2020 |
Bakhiet M, Taurin S. SARS-CoV-2: Targeted managements and vaccine development. Cytokine & Growth Factor Reviews. PMID 33293238 DOI: 10.1016/j.cytogfr.2020.11.001 |
0.072 |
|
| 2020 |
Bahman F, Taurin S, Altayeb D, Taha S, Bakhiet M, Greish K. Oral Insulin Delivery Using Poly (Styrene Co-Maleic Acid) Micelles in a Diabetic Mouse Model. Pharmaceutics. 12. PMID 33120872 DOI: 10.3390/pharmaceutics12111026 |
0.064 |
|
| 2019 |
Bahman F, Greish K, Taurin S. Nanotechnology in insulin delivery for management of diabetes. Pharmaceutical Nanotechnology. PMID 30907328 DOI: 10.2174/2211738507666190321110721 |
0.027 |
|
| Hide low-probability matches. |